• head_banner_01

OEM Manufacturer Pharmaceutical Intermediates - Cetrorelix Acetate to Prevent Premature Ovulation 120287-85-6 – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

With our excellent management, strong technical capability and strict quality control system, we continue to provide our clients with reliable quality, reasonable prices and excellent services. We aim at becoming one of your most reliable partners and earning your satisfaction for 2,5-Diaminotoluene Sulfate, 4-Methoxyphenylacetic Acid, Thallium Acetate, To learn more about what we can easily do in your case, make contact with us at any time. We glance forward to developing superior and long-term organization interactions along with you.
OEM Manufacturer Pharmaceutical Intermediates - Cetrorelix Acetate to Prevent Premature Ovulation 120287-85-6 – Gentolex Detail:

Product Detail

Name  Cetrorelix acetate
CAS number  120287-85-6
Molecular formula  C70H92ClN17O14
Molecular weight  1431.04
EINECS Number  686-384-6

Synonyms

AC-(D-ALA[3-(2-NAPHTHYL)])-[D-PHE(4-CL)]-(D-ALA[3-(3-PYRIDYL)])-SER-TYR-(D-CIT)-LEU-ARG-PRO-D-ALA-OH;Cetrorelixacetate;CETRORELIX;CETRORELIXACID;CETRIZINEDIHYDROCHLORIDE;ChemicalbookN-Acetyl-3-(2-naphthalenyl)-D-Ala-4-chloro-D-Phe-3-(3-pyridyl)-D-Ala-L-Ser-L-Tyr-N5-(aminocarbonyl)-D-Orn-L-Leu-L-Arg-L-Pro-D-Ala-NH2;Cetrorelixum;Cetrorelixum.

Description

Cetrorelix acetate is a synthetic decapeptide, which is mainly used in assisted reproductive technology to prevent premature ovulation in patients with controlled ovarian stimulation. It is a gonadotropin-releasing hormone (GnRH) antagonist that can compete with endogenous LHRH to bind to receptors on the pituitary cell membrane, thereby inhibiting the secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH) by the pituitary in a dose-dependent manner.

Cetrorelix acetate is a gonadotropin-releasing hormone (GnRH) antagonist. This product competes with endogenous GnRH for receptors on pituitary cells, thereby inhibiting the release of endogenous luteinizing hormone (LH) and follicle-stimulating hormone (FSH), delaying the appearance of the LH peak, thereby controlling ovulation. The effect of this product is dose-dependent, the inhibitory effect is direct, and is maintained by continuous treatment, without causing an initial increase in progesterone receptor activity followed by a decrease.

Equipment from Quality Department

Electric thermostatic stainless steel water bath

Box type resistance furnace

Electric heating constant temperature drying oven

Heated Incubators

Insoluble particle analyzer

Liquid chromatography

Automatic polarimeter

infrared spectrometer

UV / Visible photometer

Electric heating vacuum drying box

Vertical pressure steamer sterilizer

PH meter

Clarity Tester

Osmolality tester

Cassette Moisture Analyzer

Multi-parameter analyzer

Electric blast drying box

Biochemical incubator

Mold incubator

Aseptic isolator

Total organic carbon detector

Desktop Vacuum Dryer

Comprehensive drug stability test chamber

Constant temperature sink and water bath

Medical refrigerated storage box

Gas Chromatograph

Biological safety cabinet

Clean bench

TOC and Conductivity

TOC and conductivity of main supply and return points are monitored periodically. TOC is monitored by QC on every week. Conductivity is monitored online and recorded by purified water station operator once every four hours. The conductivity is monitored at the primary RO, secondary RO, EDI and total return point of distribution system. The specification of purified water is in place and conforms to pre-defined specification which no more than 1.3 µs/cm at 25°C (USP). For main supply and return points, full test. is performed every week, for other using point in the circulating loop, full test is performed once every month. The full test includes characters, pH, nitrate, nitrite, ammonia, conductivity, TOC, non-volatile substances, heavy metals, microbial limits and bacterial endotoxin.


Product detail pictures:

OEM Manufacturer Pharmaceutical Intermediates - Cetrorelix Acetate to Prevent Premature Ovulation 120287-85-6 – Gentolex detail pictures

OEM Manufacturer Pharmaceutical Intermediates - Cetrorelix Acetate to Prevent Premature Ovulation 120287-85-6 – Gentolex detail pictures


Related Product Guide:

With this motto in mind, we have become one of the most technologically innovative, cost-efficient, and price-competitive manufacturers for OEM Manufacturer Pharmaceutical Intermediates - Cetrorelix Acetate to Prevent Premature Ovulation 120287-85-6 – Gentolex , The product will supply to all over the world, such as: Kuwait, Kuwait, Guyana, As operation principle is "be market-oriented , good faith as principle, win-win as objective", holding on "customer first, quality assurance, service first" as our purpose, dedicated to provide the original quality, create excellence service , we won the praise and trust in the industry of auto parts. In the future, We will provide quality product and excellent service in return to our customers , welcome any suggestions and feedback from all over the world.
  • On this website, product categories is clear and rich, I can find the product I want very quickly and easily, this is really very good!
    5 Stars By Donna from London - 2018.10.01 14:14
    We feel easy to cooperate with this company, the supplier is very responsible, thanks.There will be more in-depth cooperation.
    5 Stars By Darlene from United States - 2017.08.18 11:04
    Write your message here and send it to us